Malignant transformation by ras and other oncogenes produces common alterations in inositol phospholipid signaling pathways.

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMC 280409)

Published in Proc Natl Acad Sci U S A on June 01, 1988

Authors

T Alonso1, R O Morgan, J C Marvizon, H Zarbl, E Santos

Author Affiliations

1: Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.

Articles citing this

Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells. Proc Natl Acad Sci U S A (1990) 2.26

Accumulation of p21ras.GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity. Proc Natl Acad Sci U S A (1990) 2.08

Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoylphorbol-13-acetate after transformation of NIH 3T3 cells by the Ha-ras oncogene. J Virol (1989) 1.27

Comparison of the levels of inositol metabolites in transformed haemopoietic cells and their normal counterparts. Biochem J (1993) 1.19

Persistent induction of cyclooxygenase in p60v-src-transformed 3T3 fibroblasts. Proc Natl Acad Sci U S A (1990) 1.14

Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene. Mol Cell Biol (1990) 1.13

The biochemistry of ras p21. Biochem J (1991) 1.08

Modulation of arachidonic acid metabolism by Rous sarcoma virus. J Virol (1989) 1.01

Alteration of the lipid profile in lymphomas induced by MYC overexpression. Proc Natl Acad Sci U S A (2014) 1.00

Reorganization of actin cytoskeleton by the phosphoinositide metabolite glycerophosphoinositol 4-phosphate. Mol Biol Cell (2003) 0.94

Increased conversion of phosphatidylinositol to phosphatidylinositol phosphate in Dictyostelium cells expressing a mutated ras gene. Proc Natl Acad Sci U S A (1990) 0.93

Glucocorticoid and cAMP induction mechanisms are differentially affected by the p85gag-mos oncoprotein. Proc Natl Acad Sci U S A (1989) 0.88

Fast receptor-induced formation of glycerophosphoinositol-4-phosphate, a putative novel intracellular messenger in the Ras pathway. Mol Biol Cell (1997) 0.88

Platelet-derived growth factor stimulation of GTPase-activating protein tyrosine phosphorylation in control and c-H-ras-expressing NIH 3T3 cells correlates with p21ras activation. Mol Cell Biol (1992) 0.88

Oncogene N-ras mediates selective inhibition of c-fos induction by nerve growth factor and basic fibroblast growth factor in a PC12 cell line. Mol Cell Biol (1990) 0.82

Scrape-loaded p21ras down-regulates agonist-stimulated inositol phosphate production by a mechanism involving protein kinase C. Biochem J (1989) 0.82

Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences. J Neurosci (2006) 0.81

Alterations of G-protein coupling function in phosphoinositide signaling pathways of cells transformed by ras and other membrane-associated and cytoplasmic oncogenes. Mol Cell Biol (1990) 0.80

Early regulation of membrane excitability by ras oncogene proteins. Biophys J (1990) 0.79

Induction of differentiation in v-Ha-ras-transformed MDCK cells by prostaglandin E2 and 8-bromo-cyclic AMP is associated with a decrease in steady-state level of inositol 1,4,5-trisphosphate. Mol Cell Biol (1990) 0.76

Ambient ionization mass spectrometric analysis of human surgical specimens to distinguish renal cell carcinoma from healthy renal tissue. Anal Bioanal Chem (2016) 0.76

NIH-3T3 cells transformed with a ras oncogene exhibit a protein kinase C-mediated inhibition of agonist-stimulated Ca2+ inflow. Biochem J (1990) 0.76

Articles cited by this

A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem (1985) 90.20

Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature (1984) 25.71

ras genes. Annu Rev Biochem (1987) 22.59

A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature (1986) 5.88

Requirement for c-ras proteins during viral oncogene transformation. Nature (1986) 5.24

Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science (1986) 4.99

Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc Natl Acad Sci U S A (1983) 4.82

T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes. Nature (1982) 4.54

The metabolism of phosphoinositide-derived messenger molecules. Science (1986) 3.58

Normal p21N-ras couples bombesin and other growth factor receptors to inositol phosphate production. Nature (1986) 3.41

Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency. Proc Natl Acad Sci U S A (1980) 3.29

ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites. Science (1986) 3.08

Inositol trisphosphate formation and calcium mobilization in Swiss 3T3 cells in response to platelet-derived growth factor. Biochem J (1984) 3.07

Oncogenes in solid human tumours. Nature (1982) 3.00

Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts. Nature (1987) 2.68

The ras oncogene product p21 is not a regulatory component of adenylate cyclase. Nature (1985) 2.57

Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes. Proc Natl Acad Sci U S A (1983) 2.44

ras gene Amplification and malignant transformation. Mol Cell Biol (1985) 2.02

Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins. Proc Natl Acad Sci U S A (1984) 1.94

Construction and isolation of a transforming murine retrovirus containing the src gene of Rous sarcoma virus. J Virol (1983) 1.63

Effects of bombesin and insulin on inositol (1,4,5)trisphosphate and inositol (1,3,4)trisphosphate formation in Swiss 3T3 cells. Cell (1986) 1.55

Opposing effects of a ras oncogene on growth factor-stimulated phosphoinositide hydrolysis: desensitization to platelet-derived growth factor and enhanced sensitivity to bradykinin. Proc Natl Acad Sci U S A (1987) 1.52

A guanine nucleotide-dependent phosphatidylinositol 4,5-diphosphate phospholipase C in cells transformed by the v-fms and v-fes oncogenes. J Biol Chem (1986) 1.42

Inositol phosphates. Profusion and confusion. Nature (1986) 1.36

Revertants of v-fos-transformed fibroblasts have mutations in cellular genes essential for transformation by other oncogenes. Cell (1987) 1.35

Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene. Proc Natl Acad Sci U S A (1987) 1.31

Ionomycin acts as an ionophore to release TRH-regulated Ca2+ stores from GH4C1 cells. Am J Physiol (1986) 1.19

Articles by these authors

(truncated to the top 100)

A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature (1982) 11.92

T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes. Nature (1982) 4.54

Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature (1985) 4.40

Mismatch amplification mutation assay (MAMA): application to the c-H-ras gene. PCR Methods Appl (1992) 3.42

Oncogenes in solid human tumours. Nature (1982) 3.00

Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science (1984) 2.97

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut (2005) 2.90

Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol (2001) 2.60

Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells. Proc Natl Acad Sci U S A (1982) 2.55

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction (1998) 2.47

Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone. Am J Med (1991) 2.14

ras gene Amplification and malignant transformation. Mol Cell Biol (1985) 2.02

Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins. Proc Natl Acad Sci U S A (1984) 1.94

Spontaneous activation of a human proto-oncogene. Proc Natl Acad Sci U S A (1983) 1.90

Reovirus guanylyltransferase is L2 gene product lambda 2. J Virol (1986) 1.65

Isolation and molecular characterization of the Arabidopsis TPS1 gene, encoding trehalose-6-phosphate synthase. Plant J (1998) 1.60

Localization of the normal allele of T24 human bladder carcinoma oncogene to chromosome 11. Nature (1982) 1.48

Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48

Effect of body position changes on pulmonary gas exchange in Eisenmenger's syndrome. Am J Respir Crit Care Med (1999) 1.42

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod (1994) 1.41

Right ventricular ischemia in patients with primary pulmonary hypertension. J Am Coll Cardiol (2001) 1.40

The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties. EMBO J (2000) 1.38

Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation. Mol Cell Biol (1997) 1.35

Angiotensin-stimulated production of inositol trisphosphate isomers and rapid metabolism through inositol 4-monophosphate in adrenal glomerulosa cells. Proc Natl Acad Sci U S A (1986) 1.28

Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology (2012) 1.25

N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations. Proc Natl Acad Sci U S A (1994) 1.24

Transforming genes in human tumors. J Cell Biochem (1982) 1.22

Novel aspects of gonadotropin-releasing hormone action on inositol polyphosphate metabolism in cultured pituitary gonadotrophs. J Biol Chem (1987) 1.22

Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes. Science (1991) 1.22

Induction of the HTLV-I LTR by Jun occurs through the Tax-responsive 21-bp elements. Virology (1991) 1.21

Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes. Cancer Res (1996) 1.21

Transcriptional and posttranscriptional silencing of rodent alpha1(I) collagen by a homologous transcriptionally self-silenced transgene. Mol Cell Biol (1999) 1.20

The ras signaling pathway mimics insulin action on glucose transporter translocation. Proc Natl Acad Sci U S A (1993) 1.20

Use of Veterans Affairs medical care by enrollees in Medicare HMOs. N Engl J Med (1997) 1.16

Biochemical and biological comparison of HIV-1 NEF and ras gene products. Virology (1991) 1.16

Regulation of translation in L-cells infected with reovirus. J Mol Biol (1981) 1.15

Induction by NGF of meiotic maturation of Xenopus oocytes expressing the trk proto-oncogene product. Science (1991) 1.11

An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway. Mol Cell Biol (1994) 1.07

Ras-guanine nucleotide exchange factor sos2 is dispensable for mouse growth and development. Mol Cell Biol (2000) 1.07

Activation of Ras by insulin in 3T3 L1 cells does not involve GTPase-activating protein phosphorylation. J Biol Chem (1992) 1.06

Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts. Blood (1998) 1.06

Oncogenic ras protein induces meiotic maturation of amphibian oocytes in the presence of protein synthesis inhibitors. FEBS Lett (1988) 1.05

Uptake of sucrose by Saccharomyces cerevisiae. Arch Biochem Biophys (1982) 1.05

Expression of alternative forms of Ras exchange factors GRF and SOS1 in different human tissues and cell lines. Oncogene (1996) 1.04

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcohol Clin Exp Res (1994) 1.04

The ras oncoprotein and M-phase activity. Science (1991) 1.03

Specific activation of the cellular Harvey-ras oncogene in dimethylbenzanthracene-induced mouse mammary tumors. Mol Cell Biol (1986) 1.03

A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. Oncogene (1995) 1.02

CArG binding factor A (CBF-A) is involved in transcriptional regulation of the rat Ha-ras promoter. Nucleic Acids Res (2000) 1.02

Single nucleotide polymorphism spectra in newborns and centenarians: identification of genes coding for rise of mortal disease. Gene (1998) 1.01

Effects of coumarin and 7OH-coumarin on bcl-2 and Bax expression in two human lung cancer cell lines in vitro. Cell Biol Int (2005) 0.99

Fte-1, a v-fos transformation effector gene, encodes the mammalian homologue of a yeast gene involved in protein import into mitochondria. Proc Natl Acad Sci U S A (1992) 0.98

Expression profiling of the Arabidopsis annexin gene family during germination, de-etiolation and abiotic stress. Plant Physiol Biochem (2006) 0.98

A nonradioactive, allele-specific polymerase chain reaction for reproducible detection of rare mutations in large amounts of genomic DNA: application to human k-ras. Anal Biochem (1997) 0.98

Nocturnal oxygen therapy in patients with the Eisenmenger syndrome. Am J Respir Crit Care Med (2001) 0.98

Transcriptional networks of knockout cell lines identify functional specificities of H-Ras and N-Ras: significant involvement of N-Ras in biotic and defense responses. Oncogene (2006) 0.98

Influence of pregnancy on neuromyelitis optica spectrum disorder. Neurology (2012) 0.97

Dissociation between activation of Raf-1 kinase and the 42-kDa mitogen-activated protein kinase/90-kDa S6 kinase (MAPK/RSK) cascade in the insulin/Ras pathway of adipocytic differentiation of 3T3 L1 cells. J Biol Chem (1994) 0.97

Medicare HMOs: who joins and who leaves? Am J Manag Care (1998) 0.97

Nonspecific suppressor cells in patients with chronic graft-vs-host disease after marrow grafting. J Immunol (1979) 0.97

Impact of timing of adjuvant chemotherapy initiation and completion after surgery on racial disparities in survival among women with breast cancer. Med Oncol (2013) 0.96

p21ras-induced meiotic maturation of Xenopus oocytes in the absence of protein synthesis: MPF activation is preceded by activation of MAP and S6 kinases. Oncogene (1993) 0.95

Racial and income differences in use of the hospice benefit between the medicare managed care and medicare fee-for-service. J Palliat Med (1999) 0.95

Reovirus progeny subviral particles synthesize uncapped mRNA. J Virol (1980) 0.93

Small bowel obstruction and perforation after colonoscopy. Endoscopy (2003) 0.93

Do Medicare HMOs and Medicare FFS differ in their use of the Medicare hospice benefit? Hosp J (1999) 0.92

Laser microdissection and microarray analysis of the hippocampus of Ras-GRF1 knockout mice reveals gene expression changes affecting signal transduction pathways related to memory and learning. Neuroscience (2007) 0.91

Interferon fever. Lancet (1977) 0.91

mRNA discrimination in extracts from uninfected and reovirus-infected L-cells. J Virol (1984) 0.91

Increased intracellular glycerophosphoinositol is a biochemical marker for transformation by membrane-associated and cytoplasmic oncogenes. Biochem Biophys Res Commun (1990) 0.90

In vitro synthesis of the membrane-bound D-lactate dehydrogenase of Escherichia coli. Biochemistry (1982) 0.90

Reovirus core particles synthesize capped oligonucleotides as a result of abortive transcription. Arch Biochem Biophys (1980) 0.89

A 15 amino acid stretch close to the Grb2-binding domain defines two differentially expressed hSos1 isoforms with markedly different Grb2 binding affinity and biological activity. Oncogene (1996) 0.89

[Successful endoscopic therapy in a case of Bouveret's syndrome]. Rev Esp Enferm Dig (1994) 0.88

In vitro studies of the human response to organ allografts: appearance and detection of circulating activation lymphocytes. J Immunol (1971) 0.87

Establishment of permanent brown adipocyte cell lines achieved by transfection with SV40 large T antigen and ras genes. Exp Cell Res (1993) 0.87

Adenosine as a natural prostaglandin antagonist in vascular smooth muscle. Prostaglandins (1977) 0.87

Ha-ras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontaneous mammary tumorigenesis in rats. Carcinogenesis (1996) 0.86

Treatment of type II endoleaks after endovascular repair of abdominal aortic aneurysms: translumbar puncture and injection of thrombin into the aneurysm sac. Eur J Vasc Endovasc Surg (2004) 0.86

Activation of tumor suppressor genes in nontumorigenic revertants of the HeLa cervical carcinoma cell line. Cell Growth Differ (1996) 0.85

Developmental characterization and chromosomal mapping of the 5-azacytidine-sensitive fluF locus of Aspergillus nidulans. Mol Cell Biol (1988) 0.85

Effect of decreased fte-1 gene expression on protein synthesis, cell growth, and transformation. Cell Growth Differ (1996) 0.85

Sequence and chromosomal localization of mouse annexin XI. Genomics (1996) 0.84

Lymphadenitis caused by Aerococcus urinae infection. Scand J Infect Dis (2003) 0.84

Involvement of the proton electrochemical gradient in genetic transformation in Escherichia coli. Biochem Biophys Res Commun (1981) 0.84

Stabilization and reactivation of the p53 tumor suppressor protein in nontumorigenic revertants of HeLa cervical cancer cells. Cell Growth Differ (1999) 0.84

Structure of the gene encoding anchorin CII (chick annexin V). Gene (1994) 0.84

The isoform-specific stretch of hSos1 defines a new Grb2-binding domain. Oncogene (2000) 0.84

Effect of prostacyclin on perfusion pressure, electrical activity, rate and force of contraction in isolated rat and rabbit hearts. Life Sci (1978) 0.84

Isoform-specific insertion near the Grb2-binding domain modulates the intrinsic guanine nucleotide exchange activity of hSos1. Oncogene (1999) 0.84

Dantrolene blocks intracellular calcium release in smooth muscle: competitive antagonism of thromboxane A2. Can J Physiol Pharmacol (1978) 0.84

Dependence of secretory responses to gonadotropin-releasing hormone on diacylglycerol metabolism. Studies with a diacylglycerol lipase inhibitor, RHC 80267. J Biol Chem (1988) 0.83

Transformation suppressor activity of C3G is independent of its CDC25-homology domain. Oncogene (1998) 0.83

Atriopeptin II-induced relaxation of rabbit aorta is potentiated by M&B 22,948 but not blocked by haemoglobin. Br J Pharmacol (1986) 0.83

Isolation of human monoclonal antibodies binding to B fragment of diphtheria toxin. Hum Antibodies Hybridomas (1992) 0.83

Vitreous levels of interleukine-8 and monocyte chemoattractant protein-1 in macular oedema with branch retinal vein occlusion. Eye (Lond) (2010) 0.83

Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis. Mult Scler (2009) 0.82

Biological activity of p27kip1 and its amino- and carboxy-terminal domains in G2/M transition of Xenopus oocytes. Oncogene (1997) 0.82

Why is gold such a good catalyst for oxygen reduction in alkaline media? Angew Chem Int Ed Engl (2012) 0.82

[Suppression of endogenous LH increase in ovarian stimulation with the GnRH antagonist Cetrorelix]. Geburtshilfe Frauenheilkd (1994) 0.82